CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
PR Newswire —
NEW YORK, Nov. 4, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025...